Dopamine agonist

Dopamine agonist

A dopamine agonist is a compound that activates dopamine receptors in the absence of dopamine. Dopamine agonists activate signaling pathways through the dopamine receptor and trimeric G-proteins, ultimately leading to changes in gene transcription.

Contents

Uses

Some medical drugs act as dopamine agonists and can treat hypodopaminergic (low dopamine) conditions; they are typically used for treating Parkinson's disease and certain pituitary tumors (prolactinoma), and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA-approved for the treatment of RLS. There is also an ongoing clinical trial to test the effectiveness of the dopamine agonist Requip (ropinirole) in reversing the symptoms of SSRI-induced sexual dysfunction and Post-SSRI sexual dysfunction (PSSD).[1] Additionally, a systematic review and meta-analysis concluded that prophylactic treatment with cabergoline reduces the incidence, but not the severity, of ovarian hyperstimulation syndrome (OHSS), without compromising pregnancy outcomes, in females undergoing stimulated cycles of in vitro fertilization (IVF).[2]

Side-effects

Some of the common side effects of dopamine agonists include:[3][4]

  • Euphoria
  • Hallucinations
  • Causing or worsening psychosis
  • Orthostatic hypotension
  • Increased orgasmic intensity
  • Weight loss
  • Nausea
  • Insomnia
  • Unusual tiredness or weakness
  • Dizziness, drowsiness, lightheadedness, or fainting
  • Twitching, twisting, or other unusual body movements
  • Pathological addiction (gambling, shopping, internet pornography, hyper-sexuality) – specifically D3-preferring agonists

Examples

Examples of dopamine agonists include:

Some, such as fenoldopam, are selective for dopamine receptor D1.[6]

See also

References

  1. ^ ClinicalTrials.gov NCT00334048 - "Treating Sexual Dysfunction From SSRI Medication: a Study Comparing Requip CR to Placebo"
  2. ^ Youssef MA, van Wely M, Hassan MA, et al. (March 2010). "Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis". Hum Reprod Update 16 (5): 459–66. doi:10.1093/humupd/dmq006. PMID 20354100. http://humupd.oxfordjournals.org/cgi/content/abstract/16/5/459?etoc. 
  3. ^ "MedlinePlus Drug Information: Pramipexole (Systemic)". United States National Library of Medicine. Archived from the original on 2006-09-26. http://web.archive.org/web/20060926023858/http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203739.html. Retrieved 2006-09-27. 
  4. ^ Boyd, Alan (1995). "Bromocriptine and psychosis: A literature review". Psychiatric Quarterly 66 (1): 87–95. doi:10.1007/BF02238717. PMID 7701022. http://www.springerlink.com/content/y42v466374524k1m/. Retrieved 2008-09-06. 
  5. ^ FDA Announces Voluntary Withdrawal of Pergolide Products
  6. ^ Ng SS, Pang CC (March 2000). "In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist". Br. J. Pharmacol. 129 (5): 853–8. doi:10.1038/sj.bjp.0703119. PMC 1571905. PMID 10696081. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1571905. 

6. Avanzi M, Uber E, Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease. Neurol Sci 2004; 25:98–101[Medline]

External links


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать реферат

Look at other dictionaries:

  • Dopamine — For other uses, see Dopamine (disambiguation). Dopamine …   Wikipedia

  • Dopamine dysregulation syndrome — Three dimensional model of the structure of a dopamine molecule. Dopamine is at the origin of DDS. Dopamine dysregulation syndrome (DDS), sometimes known as hedonistic homeostatic dysregulation in Parkinson s disease, is a dysfunction of the… …   Wikipedia

  • Dopamine receptor D4 — Identifiers Symbols DRD4; D4DR External IDs OMIM:  …   Wikipedia

  • Dopamine receptor D2 — Rendering based on PDB 1I15 …   Wikipedia

  • Dopamine receptor D3 — Dopamine D3 receptor with Eticlopride(PDB 3PBL) …   Wikipedia

  • Dopamine receptor D1 — Identifiers Symbols DRD1; DADR; DRD1A External IDs OMIM: …   Wikipedia

  • Dopamine reuptake inhibitor — Dopamine A dopamine reuptake inhibitor (DRI, DARI) is a type of drug that acts as a reuptake inhibitor for the neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). This in turn leads to increased extracellular… …   Wikipedia

  • Dopamine receptor — Dopamine Dopamine receptors are a class of metabotropic G protein coupled receptors that are prominent in the vertebrate central nervous system (CNS). The neurotransmitter dopamine is the primary endogenous ligand for dopamine receptors. Dopamine …   Wikipedia

  • Dopamine beta hydroxylase deficiency — Classification and external resources Dopamine beta hydroxylase is the enzyme responsible for converting dopamine (pictured) to norepinephrine. OMIM …   Wikipedia

  • Dopamine antagonist — Skeletal formula of clozapine, the first atypical antipsychotic, a dopamine antagonist. A dopamine antagonist is a drug which blocks dopamine receptors by receptor antagonism. There are five known types of dopamine receptors in the human body;… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”